Clinical Trial Update: Tailored Antiplatelet Therapy Following PCI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tailored antiplatelet therapy after PCI for coronary artery disease and acute coronary syndrome; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Stenosis

Snippet

Sponsor: Mayo Clinic | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2021-11-09